Functional significance of inflammatory mediators in a murine model of resuscitated hemorrhagic shock

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 288, Issue 3 57-3, 2005, Pages

  Vallejo, Jesus G ^a   Nemoto, Shintaro ^a   Ishiyama, Masakuni ^a   Yu, Bi ^a   Knuefermann, Pascal ^a   Diwan, Abinav ^a   Baker, J Scott ^a   Defreitas, Gilberto ^a   Tweardy, David J ^a   Mann, Douglas L ^a,b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b Winters Ctr for Heart Failure Res   (United States)

Author keywords

Left ventricular function; Soluble tumor necrosis factor receptor antagonist; Tumor necrosis factor

Indexed keywords

ETANERCEPT; INTERLEUKIN 1BETA; INTERLEUKIN 6; MYELOPEROXIDASE; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE FUNCTION; HEMORRHAGIC SHOCK; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; INFLAMMATION; MALE; MEAN ARTERIAL PRESSURE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REPERFUSION INJURY; RESUSCITATION; RIBONUCLEASE PROTECTION ASSAY; TWO DIMENSIONAL ECHOCARDIOGRAPHY;

ANIMALS; BIOLOGICAL RESPONSE MODIFIERS; DISEASE MODELS, ANIMAL; FEMALE; IMMUNOGLOBULIN G; INFLAMMATION MEDIATORS; INTERLEUKIN-1; INTERLEUKIN-6; MALE; MICE; MICE, INBRED C57BL; RECEPTORS, TUMOR NECROSIS FACTOR; RESUSCITATION; SHOCK, HEMORRHAGIC; TUMOR NECROSIS FACTOR-ALPHA; VENTRICULAR DYSFUNCTION, LEFT;

EID: 13944255828     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.01003.2003     Document Type: Article

References (25)

1. Altavilla D, Saitta A, Guarini S, Galeano M, Squadrito G, Cucinotta D, Santamaria B, Mazzeo AT, Campo GM, Ferlito M, Minutoli L, Bazzani C, Bertolini A, Caputi AP, and Squadrito F. Oxidative stress causes nuclear factor-κB activation in acute hypovolemic hemorrhagic shock. Free Radice Biol Med 30: 1055-1066, 2001.
2. Bolli R, Jeroudi MO, Patel BS, DuBose CM, Lai EK, Roberts R, and McCay PB. Direct evidence that oxygen-derived free radicals contribute to postischemic myocardial dysfunction in the intact dog. Proc Natl Acad Sci USA 86: 4695-4699, 1989.
3. Bolli R, Patel BS, Jeroudi MO, Lai EK, and McCay. Demonstration of free radical generation in "stunned7quot; myocardium of intact dogs with the use of the spin trap α-phenyl N-tert-butyl nitrone. J Clin Invest 82: 476-485, 1988.
4. Diwan A, Tran T, Misra A, and Mann DL. Inflammatory mediators and the failing heart: a translational approach. Curr Molec Med 3: 161-182, 2003.
5. Fentzke RC, Korcarz CE, Shroff SG, Lin H, Sandelski J, Leiden JM, and Lang RM. Evaluation of ventricular and arterial hemodynamics in anesthetized closed-chest mice. J Am Soc Echocardiogr 10: 915-925, 1997.
6. Gross SD. Physiology of shock. In: Shock, edited by Davis HA. New York: Grune & Stratton, 2001, p. 3.
7. Hierholzer C, Harbrecht B, Menezes JM, Kane J, MacMicking J, Nathan CF, Peitzman AB, Billiar TR, and Tweardy DJ. Essential role of induced nitric oxide in the initiation of the inflammatory response after hemorrhagic shock. J Exp Med 187: 917-928, 1998.
8. Hoeft A and Mann DL. Myocardial dysfunction in septic shock: basic mechanisms and emerging concepts. Curr Opin Anesth 1: 26-32, 1994.
9. Horton JW. Hemorrhagic shock depresses myocardial contractile function in the guinea pig. Circ Shock 28: 23-35, 1989.
10. Lange LG and Schreiner GF. Immune cytokines and cardiac disease. TCM 2: 145-151, 1992.
11. Mann DL. Cytokines as mediators of disease progression in the failing heart. In: Congestive Heart Failure, edited by Hosenpud JD and Greenberg BH. Philadelphia, PA: Lippincott, Williams & Wilkins, 1999, p. 213-232.
12. McCord JM. Oxygen-derived free radicals in postischemic tissue injury. N Engl J Med 312: 159-163, 1985.
13. Meldrum DR, Meng X, Dinarello CA, Ayala A, Cain BS, Shames BD, Ao L, Banerjee A, and Harken AH. Human myocardial tissue TNFα expression following acute global ischemia in vivo. J Mol Cell Cardiol 30: 1683-1689, 1998.
14. Meldrum DR, Shenkar R, Sheridan BC, Cain BS, Abraham E, and Harken AH. Hemorrhage activates myocardial NF-κB and increases TNF-α in the heart. J Mol Cell Cardiol 29: 2849-2854, 1997.
15. Nemoto S, Vallejo JG, Knuefermann P, Misra A, DeFreitas G, Carabello BA, and Mann DL. Escherichia coli lipolysaccharide-induced left ventricular dysfunction: the role of toll-like receptor-4 in the adult mammalian heart. Am J Physiol Heart Circ Physiol 282: H2316-H2323, 2002.
16. Oral H, Kapadia S, Nakano M, Torre-Amione G, Lee J, Lee-Jackson D, Young JB, and Mann DL. Tumor necrosis factor-α and the failing human heart. Clin Cardiol 18: IV-20-IV-27, 1995.
17. Peitzman AB, Billiar TR, Harbrecht BG, Kelly E, Udekwu AO, and Simmons RL. Hemorrhagic shock. Curr Probl Surg 32: 925-1002, 1995.
18. Shahani R, Klein LV, Marshall JG, Nicholson S, Rubin BB, Walker PM, and Lindsay TF. Hemorrhage-induced a-adrenergic signaling results in myocardial TNF-α expression and contractile dysfunction. Am J Physiol Heart Circ Physiol 281: H84-H92, 2001.
19. Shahani R, Marshall JG, Rubin BB, Li RK, Walker PM, and Lindsay TF. Role of TNF-α in myocardial dysfunction after hemorrhagic shock and lower-torso ischemia. Am J Physiol Heart Circ Physiol 278: H942-H950, 2000.
20. Siegel HW and Downing SE. Contributions of coronary perfusion pressure, metabolic acidosis and adrenergic factors to the reduction of myocardial contractility during hemorrhagic shock in the cat. Circ Res 21: 875-889, 2001.
21. Squadrito F, Altavilla D, Ioculano M, Calapai G, Zingarelli B, Saitta A, Campo GM, Rizzo A, and Caputi AP. Passive immunization with antibodies against tumor necrosis factor (TNF-α) protects from the lethality of splanchnic artery occlusion shock. Circ Shock 37: 236-244, 1992.
22. Tamion F, Richard V, Bonmarchand G, Leroy J, Hiron M, Daveau M, Thuillez C, and Lebreton JP. Reduced synthesis of inflammatory cytokines by a free radical scavenger after hemorrhagic shock in rats. Crit Care Med 28: 2522-2527, 2000.
23. 2-terminal kinase). Eur J Biochem 244: 587-595, 1997.
24. Yao YM, Bahrami S, Redl SH, and Schlag G. Monoclonal antibody to tumor necrosis factor-α attenuates hemodynainic dysfunction secondary to intestinal ischemia/reperfusion in rats. Crit Care Med 24: 1547-1553, 1996.
25. Zingarelli B, Squadrito F, Altavilla D, Calapai G, Di Rosa M, and Caputi AP. Role of tumor necrosis factor-α in acute hypovolemic hemorrhagic shock in rats. Am J Physiol Heart Circ Physiol 266: H1512-H1515, 1994.